Cooper Companies (The) (COO) Q1 2025 10-Q Quarterly Report
Cooper Companies (The) (COO) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on Mar 7, 2025 for the fiscal period ending Jan 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Cooper Companies (The) Q1 2025 10-Q Analysis
Risk Factors
- • No new or materially changed risk factors reported since 2024 10-K filing
- • Regulatory risk focused on FDA and NMPA approvals for MiSight 1 day myopia management lens in US and China
- • Competitive risk from evolving contact lens market shifting toward single-use silicone hydrogel products like clariti and MyDay
- • Operational risk from integration and market expansion of CooperSurgical products, including fertility and cryostorage services
- • Intellectual property risk from protecting patents, trademarks, trade secrets across US and international markets
Cooper Companies (The) Q1 2025 Quarterly FinancialsXBRL
Revenue
$965M
▲ +3.6% YoY
Net Income
$104M
▲ +28.4% YoY
Gross Margin
68.4%
▲ +148bp YoY
Operating Margin
18.9%
▲ +243bp YoY
Net Margin
10.8%
▲ +210bp YoY
EPS (Diluted)
$0.52
▲ +26.8% YoY
Operating Cash Flow
$191M
▲ +55.3% YoY
Source: XBRL data from Cooper Companies (The) Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Cooper Companies (The) Quarterly Reports
Get deeper insights on Cooper Companies (The)
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.